Research News

Alendronate may cut hip fracture risk in older patients taking prednisolone

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3348 (Published 11 July 2017) Cite this as: BMJ 2017;358:j3348
  1. Jacqui Wise
  1. London

Older patients who take the anti-inflammatory steroid prednisolone would benefit from treatment with the osteoporosis drug alendronate because it reduces the risk of hip fracture, a retrospective cohort study published in JAMA has found.1

Glucocorticoid therapy is widely used to treat inflammatory conditions and is commonly prescribed for patients over 65. However, it can lead to rapid bone loss and …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe